Neuregulin-1/NRG1 Antibody (NRG1/2752) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-79847H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Protein Array
Label
HRP
Antibody Source
Monoclonal Mouse IgG Clone # NRG1/2752
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment of human Neuregulin-1/NRG1 protein (around aa 21-242) (exact sequence is proprietary) (Uniprot: Q02297)
Localization
Cell Surface, Cytoplasmic (Secreted)
Marker
Breast and Urothelial Marker
Clonality
Monoclonal
Host
Mouse
Isotype
IgG
Applications for Neuregulin-1/NRG1 Antibody (NRG1/2752) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Protein Array
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Neuregulin-1/NRG1
Alternate Names
Heregulin-1, HGL, HRG1-alpha, HRG1-beta 1, Neuregulin1, NRG1
Gene Symbol
NRG1
Additional Neuregulin-1/NRG1 Products
Product Documents for Neuregulin-1/NRG1 Antibody (NRG1/2752) [HRP]
Product Specific Notices for Neuregulin-1/NRG1 Antibody (NRG1/2752) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...